| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |